{"id":3058,"date":"2018-05-22T12:48:23","date_gmt":"2018-05-22T16:48:23","guid":{"rendered":"http:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone.jpg"},"modified":"2018-05-22T12:48:51","modified_gmt":"2018-05-22T16:48:51","slug":"figure-2-the-original-oidd-program-infrastructure-was-established-with-it-and-business-functions-alone","status":"inherit","type":"attachment","link":"https:\/\/www.drugpatentwatch.com\/blog\/?attachment_id=3058","title":{"rendered":"Figure 2 &#8211; The original OIDD program infrastructure was established with IT and Business functions alone"},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"_lmt_disableupdate":"","_lmt_disable":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"class_list":["post-3058","attachment","type-attachment","status-inherit","hentry"],"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone.jpg'><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"104\" src=\"https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-300x104.jpg\" class=\"attachment-medium size-medium\" alt=\"Figure 2 - The original OIDD program infrastructure was established with IT and Business functions alone\" srcset=\"https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-300x104.jpg 300w, https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-600x208.jpg 600w, https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-64x22.jpg 64w, https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-768x266.jpg 768w, https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-640x222.jpg 640w, https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone.jpg 836w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n"},"caption":{"rendered":"<p>Figure 2. The original OIDD program infrastructure was established with IT and Business functions alone. As the program grew, and the volume and complexity of submissions increased, the composition of the dedicated team evolved to an even distribution of IT, Business, and Scientific resources.<\/p>\n"},"alt_text":"Figure 2 - The original OIDD program infrastructure was established with IT and Business functions alone","media_type":"image","mime_type":"image\/jpeg","media_details":{"width":836,"height":290,"file":"2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone.jpg","filesize":23812,"sizes":{"woocommerce_thumbnail":{"file":"Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-300x104.jpg","width":300,"height":104,"filesize":6680,"uncropped":true,"mime_type":"image\/jpeg","source_url":"https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-300x104.jpg"},"woocommerce_gallery_thumbnail":{"file":"Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-100x100.jpg","width":100,"height":100,"filesize":3605,"mime_type":"image\/jpeg","source_url":"https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-100x100.jpg"},"woocommerce_single":{"file":"Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-600x208.jpg","width":600,"height":208,"filesize":16380,"mime_type":"image\/jpeg","source_url":"https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-600x208.jpg"},"dgwt-wcas-product-suggestion":{"file":"Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-64x22.jpg","width":64,"height":22,"filesize":1111,"mime_type":"image\/jpeg","source_url":"https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-64x22.jpg"},"thumbnail":{"file":"Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-150x150.jpg","width":150,"height":150,"mime_type":"image\/jpeg","source_url":"https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-150x150.jpg"},"medium":{"file":"Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-300x104.jpg","width":300,"height":104,"mime_type":"image\/jpeg","source_url":"https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-300x104.jpg"},"medium_large":{"file":"Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-768x266.jpg","width":768,"height":266,"mime_type":"image\/jpeg","source_url":"https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-768x266.jpg"},"two-columns":{"file":"Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-640x222.jpg","width":640,"height":222,"mime_type":"image\/jpeg","source_url":"https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone-640x222.jpg"},"full":{"file":"Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone.jpg","width":836,"height":290,"mime_type":"image\/jpeg","source_url":"https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone.jpg"}},"image_meta":{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0","keywords":[]}},"post":3054,"source_url":"https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2018\/05\/Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone.jpg","filename":"Figure-2-The-original-OIDD-program-infrastructure-was-established-with-IT-and-Business-functions-alone.jpg","filesize":23812,"_links":{"self":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/media\/3058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/comments?post=3058"}]}}